Pfizer Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Pfizer Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 26.1 times. Higher than 98% of Healthcare companies in India.
- Debt Due Cover Ratio: Debt due within a year is covered 387.0 times by its yearly operating cash. Higher than 98% of Healthcare companies in India.
- Cash Cushion Ratio: Cash, after subtracting all debt, equals 18% of its market value (net cash). Higher than 96% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹92Over the last 3 years, every ₹100 of reported profit came with ₹92 of operating cash.
Lower than 57% of Healthcare companies in India.
Self-Funding Ratio
26.1×Over the last 3 years its own operating cash covered its investment spending (capex) 26.1 times.
Higher than 98% of Healthcare companies in India.
Cash Locked Ratio
₹7For every ₹100 of sales, ₹7 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹7 tied up three years earlier.
Less money tied up than 76% of Healthcare companies in India.
Growth quality
Steadiness Ratio
2/3 · 1/3Sales grew in 2 of the last 3 years; profit grew in 1 of 3.
Less steady than 84% of Healthcare companies in India.
Growth Efficiency Ratio
—Sales barely changed
Sales changed by +4% in 3 years, too little to measure extra profit per extra sales.
Asset Productivity Ratio
+4% / +23%In 3 years sales changed by +4% while total assets changed by +23%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
387.0×Debt due within a year is covered 387.0 times by its yearly operating cash.
Higher than 98% of Healthcare companies in India.
Cash Cushion Ratio
+18%Cash, after subtracting all debt, equals 18% of its market value (net cash).
Higher than 96% of Healthcare companies in India.
Tangible Assets Ratio
89%Of every ₹100 the company owns, ₹89 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 72% of Healthcare companies in India.
Tangible Net Worth Ratio
87%Of every ₹100 of net worth, ₹87 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 63% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Pfizer Limited owes ₹0.15 for every ₹1 it owns. Net profit fell 6% in the year to Mar 2026, and grew 5% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
23.0Investors pay ₹23.0 for every ₹1 of Pfizer Limited's yearly profit, lower than 77% of Healthcare companies in India.
P/B ratio
4.02The share price is 4.02 times Pfizer Limited's book value per share, lower than 59% of Healthcare companies in India.
Market cap
₹16,876 CrThe total market value of all of Pfizer Limited's shares at today's price (share price × number of shares), larger than 76% of Healthcare companies in India. PosiCap size class: Meso Cap.
Net worth (book value)
₹4,203 CrWhat Pfizer Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹918.71Net worth divided by the number of shares. The share price of ₹3,689 is 4.0 times this, which is the P/B above.
Return on equity (ROE)
17.5%Pfizer Limited earned 17.5% on its shareholders' money over the last year, higher than 71% of Healthcare companies in India.
Owes vs Owns
0.15×Pfizer Limited owes ₹0.15 for every ₹1 it owns (low), lower than 93% of Healthcare companies in India.
Dividend yield
2.00%Pfizer Limited pays 2.00% of its share price as dividends a year, higher than 92% of dividend-paying Healthcare companies in India.
Revenue growth
+10%Revenue rose 10% in the year to Mar 2026, and grew 1% a year on average over 3 years.
Profit growth
-6%Net profit fell 6% in the year to Mar 2026, and grew 5% a year on average over 3 years.
Profit margin
28.7%Pfizer Limited keeps ₹29 of every ₹100 of revenue as net profit.
Cash quality
1.3×Cash from Pfizer Limited's business was 1.3× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
89.4×Pfizer Limited's operating profit covered its interest costs 89.4 times in the year to Mar 2026.
Cash vs debt
Net cashPfizer Limited held ₹3,018 Cr more cash than debt (net cash) at Mar 2026.
Questions
What is Pfizer Limited's P/E ratio?
Investors pay ₹23.0 for every ₹1 of Pfizer Limited's yearly profit, lower than 77% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Pfizer Limited: ₹16,876 Cr ÷ ₹4,203 Cr (31 Mar 2026) = 4.0.
What is Pfizer Limited's return on equity?
Pfizer Limited earned 17.5% on its shareholders' money over the last year, higher than 71% of Healthcare companies in India.
How much does Pfizer Limited owe compared with what it owns?
Pfizer Limited owes ₹0.15 for every ₹1 it owns (low), lower than 93% of Healthcare companies in India.
Does Pfizer Limited pay a dividend?
Yes. Pfizer Limited pays 2.00% of its share price as dividends a year, higher than 92% of dividend-paying Healthcare companies in India.
Is Pfizer Limited's revenue growing?
Revenue rose 10% in the year to Mar 2026, and grew 1% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.